Stocks & Investing
Stocks and Investing
Stocks and Investing
Sun, January 30, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, January 28, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Matthew Biegler Initiated (CELU) at Buy and Held Target at $90 on, Jan 28th, 2022
Matthew Biegler of Oppenheimer, Initiated "Celularity Inc." (CELU) at Buy and Held Target at $90 on, Jan 28th, 2022.
Matthew has made no other calls on CELU in the last 4 months.
There are 2 other peers that have a rating on CELU. Out of the 2 peers that are also analyzing CELU, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Initiated at Hold and Held Target at $90 on, Wednesday, November 24th, 2021
This is the rating of the analyst that currently disagrees with Matthew
- Asthika Goonewardene of "Truist Securities" Initiated at Strong Buy and Held Target at $120 on, Tuesday, October 19th, 2021
